凝聚胺交叉配血不合患者输血的安全管理和风险控制

发布时间：2018-07-18 10:59

【摘要】：目的探讨凝聚胺交叉配血不合患者输血的安全管理和风险控制。方法 2015年10-11月通过建立健全完善输血管理规章制度,加强医务人员的专业和法律法规知识培训,提高医务人员临床输血知识水平和法律意识,使其充分认识输血风险。输用凝聚胺法交叉配血不相容血液前必须得到患方同意,签署各项知情同意书后方可实施输血治疗,输血时缓慢滴注,严密观察,一旦出现输血不良反应,立即停止输注并积极处理抢救。实行输血病历标准化书写管理,使输血医疗文书能够全面真实地反映输血全过程。结果 5例患者经原发疾病治疗和输血、对症治疗后病情好转,自觉症状减轻,无晕厥、心绞痛、胸闷症状,贫血改善,血红蛋白上升,最低者62 g/L,最高者102 g/L,未发生严重的输血不良反应和医疗纠纷。结论凝聚胺交叉配血不合患者输血相较于普通输血风险更高,只有做好系统性的安全管理和风险控制,才能提高输血疗效,减少输血风险,确保患者和医务人员的安全,避免医疗纠纷发生。
[Abstract]:Objective to explore the safety management and risk control of blood transfusion in patients with polyamines cross matching blood discompatibility. Methods through establishing and perfecting the regulations and regulations of blood transfusion management in 10-11 months of 2015, strengthening the professional and legal knowledge training of medical personnel, improving the knowledge level of clinical transfusion and legal consciousness of medical staff, so that they can fully understand the risk of blood transfusion. It is necessary to get the consent of the patient before the transfusion of blood incompatible blood by the method of polyamines. Results the whole process of blood transfusion was fully and truly reflected. Results 5 patients were treated with primary disease and blood transfusion. After symptomatic treatment, the condition was improved, symptoms were relieved, no syncope, angina, chest distress, anemia improved, hemoglobin rose, the lowest was 62 g/L, the highest was 102 g/L, and there was no serious adverse reaction and medical dispute. Conclusion coagulation The risk of blood transfusion is higher than that of ordinary blood transfusion. Only the systematic safety management and risk control can improve the effect of blood transfusion, reduce the risk of blood transfusion, ensure the safety of the patients and medical staff, and avoid the medical disputes.
【作者单位】：温州市中心医院血液化疗科;
【分类号】：R457.1

【相似文献】